You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
英科醫療(300677.SZ)擬設立控股子公司實施泗陽非織造原料生產線及醫療用品生產製造項目
格隆匯 07-01 21:09

格隆匯 7 月 1日丨英科醫療(300677.SZ)公佈,為滿足未來戰略發展需要,促進資源利用效率,2020年7月1日公司與江蘇泗陽經濟開發區管理委員會正式簽訂了《江蘇泗陽經濟開發區工業項目進區合同書》,以實施泗陽非織造原料生產線及醫療用品生產製造項目。為實施上述項目,公司擬與陳清共同出資設立控股子公司江蘇英偉醫療有限公司(以工商部門最後核准名稱為準),註冊資本為人民幣2億元,其中公司以貨幣方式認繳出資人民幣1.4億元,佔註冊資本的70.00%,資金來源為公司自有資金;陳清以貨幣方式認繳出資人民幣6000萬元,佔註冊資本的30.00%。

公司在江蘇泗陽縣設立控股子公司目的是為實施泗陽非織造原料生產線及醫療用品生產製造項目,符合公司長期發展戰略和投資方向,有利於進一步增強公司的整體實力,優化公司產能及戰略佈局,鞏固公司在行業內的地位。資金來源為公司自有資金或自籌資金,不會對公司的生產經營產生不利影響,不存在損害公司及全體股東利益的情形。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account